Pharma social listening

Indication-depth insight — not just volume and sentiment

IndicationIQ is pharma social listening for insight and medical communications teams: ranked unmet needs and HCP signals from public conversation, every one backed by a verbatim quote.

What you get

Outputs insight teams can put in front of medical review

Named unmet needs

Specific challenges in patient language — sized by frequency within one indication.

HCP professional signals

Launch-window and medical-communications themes from public professional commentary.

Verbatim evidence trail

Every insight links to source, date, and quote for medical and compliance review.

Human-reviewed exports

Automation proposes; reviewers approve before anything reaches a client deliverable.

Clear category fit

Built for patient insight — not every job labelled “listening”

IndicationIQ is

  • Indication-first collection from public open sources
  • Ranked unmet needs, misconceptions, and HCP signals
  • Privacy defaults: anonymised exports, erasure, retention lifecycle

IndicationIQ is not

  • A replacement for pharmacovigilance / AE reporting systems
  • A brand mention dashboard that stops at sentiment
  • A cross-indication database of identifiable patients

FAQ

Pharma social listening questions

What is pharma social listening?
Pharma social listening is the practice of monitoring public digital conversation for pharmaceutical research and operations. Depending on the team, that can mean adverse-event monitoring, brand reputation tracking, or patient and HCP insight. IndicationIQ focuses on the insight job: indication-scoped unmet needs and signals with evidence.
How is IndicationIQ different from other pharma social listening tools?
Many tools optimise for volume, sentiment, alerts, or AE triage. IndicationIQ turns public conversation into named unmet needs and HCP signals — sized by frequency, linked to verbatims, and structured for human-reviewed client deliverables.
Which sources do you cover?
Public open sources configured per project — including Reddit, X, Bluesky, YouTube, and public forums. Availability depends on integrations; every project uses indication-specific clinical and lay keywords.
Is this suitable for regulated pharma work?
Yes for insight deliverables that need provenance, human review, and privacy controls. It does not replace your organisation’s medical, legal, privacy, or regulatory review — or dedicated PV systems.

See IndicationIQ on your therapy area

Request a demo for patient support, HCP launch, or agency delivery workflows.

Request a demo